✦ The floor
Discussion
Signed responses from readers of the wire.
✦ Clinical Takeaway ✦
No actionable change — this is an erratum; clinicians should check the corrected version of the original article if they rely on it for prescribing guidance, but no new clinical evidence is introduced.
✦ Why It Matters ✦
Published corrections are important for maintaining research integrity, and clinicians using the original flunarizine/cinnarizine study for treatment decisions should ensure they reference the corrected version.
✦ Key Points ✦
- 01This is a correction (erratum) to a previously published 8-month retrospective study.
- 02Original study examined flunarizine and cinnarizine as preventive treatments for vestibular migraine and migraine-associated Meniere's disease.
- 03No new data or findings are introduced in the correction notice.
- 04Clinicians referencing the original article should obtain the corrected version.
- 05Retrospective design of the original study limits the strength of its conclusions.
✦ Research metadata ✦
- PMID
- 42900214
- DOI
- 10.1007/s00405-026-10671-5.
- Journal
- European Archives of Oto-Rhino-Laryngology
- Publication type
- editorial
- Evidence level
- 4
- Population
- Patients with vestibular migraine or migraine-associated Meniere's disease
- Intervention
- Flunarizine and cinnarizine prophylaxis
Primary outcomes
Prevention of vestibular migraine episodes; Prevention of migraine-associated Meniere's disease episodes